Details of the Drug Reposition

General Information of This Drug (ID: DMKU3R1)

Drug Name
Dusquetide   DMKU3R1
Synonyms
931395-42-5; UNII-IKX7W49NLN; RIVPA; (S)-1-(L-arginyl-L-isoleucyl-L-valyl)-N-((S)-1-amino-1-oxopropan-2-yl)pyrrolidine-2-carboxamide; IKX7W49NLN; SGX94; SGX942; Dusquetide (USAN/INN); L-arginyl-L-isoleucyl-L-valyl-L-prolyl-L-alaninamide; SGX-94; CHEMBL3545314; SCHEMBL16671001; IMX-942; SGX-942; HY-P2076; CS-0107857; J3.575.671J; D11751; Q27280772; (2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]-N-[(2S)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
Drug Type
Peptide
Structure
3D MOL is unavailable 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Oral cavity squamous cell carcinoma DISQVJVA 2B6E.0 Phase 3 [1]
Oral mucositis DISS93V5 DA01.11 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03237325) DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer. U.S. National Institutes of Health.